Mast cell activation mediates blood–brain barrier impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Introduction: Sepsis-associated encephalopathy (SAE) is a diffuse cerebral dysfunction resulting from a systemic inflammatory response to infection; however, its pathophysiology remains unclear. Sepsis-induced neuroinflammation and blood–brain barrier (BBB) disruption are crucial factors in brain function disturbance in SAE. Mast cells (MCs) activation plays an important role in several neuroinflammation models; however, its role in SAE has not been comprehensively investigated. Methods: We first established a SAE model by cecal ligation puncture (CLP) surgery and checked the activation of MCs. MCs activation was checked using immumohistochemical staining and Toluidine Blue staining. We administrated cromolyn (10mg/ml), a MC stabilizer, to rescue the septic mice. Brain cytokines levels were measured using biochemical assays. BBB disruption was assessed by measuring levels of key tight-junction (TJ) proteins. Cognitive function of mice was analyzed by Y maze and open field test. Transwell cultures of brain microvascular endothelial cells (BMVECs) co-cultured with MCs were used to assess the interaction of BMVECs and MCs. Results: Results showed that MCs were overactivated in the hippocampus of CLP-induced SAE mice. Cromolyn intracerebroventricular (i.c.v) injection substantially inhibited the MCs activation and neuroinflammation responses, ameliorated BBB impairment, improved the survival rate and alleviated cognitive dysfunction in septic mice. In vitro experiments, we revealed that MCs activation increased the sensitivity of BMVECs against to lipopolysaccharide (LPS) challenge. Furthermore, we found that the histamine/histamine 1 receptor (H1R) mediated the interaction between MCs and BMVECs, and amplifies the LPS-induced inflammatory responses in BMVECs by modulating the TLR2/4-MAPK signaling pathway. Conclusions: MCs activation could mediate BBB impairment and cognitive dysfunction in septic mice in a histamine-dependent pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The cascade reaction between myeloid cells and vascular endothelium induces microthrombus formation and perfusion disturbances, forming a central regulatory network of the vascular-immune-neural axis [43].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mast cells exacerbate BBB injury and cognitive impairment through the histamine/H1R-TLR2/4-MAPK axis, enhancing the inflammatory response in BMECs.”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437 · cited 2×
“Increasing evidence indicates that the integrity and permeability of BBB are impaired during sepsis (5, 41).”
BackgroundCecconi, M., Evans, L., Levy, M., & Rhodes, A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30696-2 · Cited by 2,254 · cited 1×
“Sepsis is also considered the main killer in intensive care units due to higher mortality rates as well as multiple organ infection at the same time (2).”
BackgroundThe immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957 · cited 1×
“BBB dysfunction contributes highly to the pathophysiology of SAE (18).”
BackgroundMetcalfe, D. D., Baram, D., & Mekori, Y. A. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1033 · Cited by 1,724
Annane, D., Bellissant, E., & Cavaillon, J.-M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17667-8 · Cited by 1,213
Mast Cell: A Multi-Functional Master Cell
Krystel-Whittemore, M., Dileepan, K. N., & Wood, J. G. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00620 · Cited by 890
Mast Cell Function: A New Vision of an Old Cell
da Silva, E. Z. M., Jamur, M. C., & Oliver, C. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414545334 · Cited by 604
Septic-Associated Encephalopathy: a Comprehensive Review
Mazeraud, A., Righy, C., Bouchereau, E., Benghanem, S., Bozza, F. A., & Sharshar, T. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00862-1 · Cited by 328
Sepsis-Associated Encephalopathy and Blood-Brain Barrier Dysfunction
Gao, Q., & Hernandes, M. S. (2021) · Inflammation · doi:10.1007/s10753-021-01501-3 · Cited by 257
Fu, Q., Wu, J., Zhou, X.-Y., Ji, M.-H., Mao, Q.-H., Li, Q., Zong, M.-M., Zhou, Z.-Q., & Yang, J.-J. (2019) · Inflammation · doi:10.1007/s10753-018-0894-4 · Cited by 232
Epidemiology of sepsis and septic shock
Chiu, C., & Legrand, M. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000958 · Cited by 232
TNFα Transport across the Blood–Brain Barrier Is Abolished in Receptor Knockout Mice
Pan, W., & Kastin, A. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7871 · Cited by 210
Dong, H., Zhang, W., Zeng, X., Hu, G., Zhang, H., He, S., & Zhang, S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8697-6 · Cited by 165
Histamine–cytokine connection in immunity and hematopoiesis
Dy, M., & Schneider, E. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.06.003 · Cited by 161
Tissue distribution of histamine in a mutant mouse deficient in mast cells
Atsushi, Y., Kazutaka, M., Takehiko, W., Hiroshi, W., & Yukihiko, K. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90175-7 · Cited by 160
Mast Cells Are Early Responders After Hypoxia-Ischemia in Immature Rat Brain
Jin, Y., Silverman, A. J., & Vannucci, S. J. (2009) · Stroke · doi:10.1161/strokeaha.109.549691 · Cited by 141
Singleton, K. D., & Wischmeyer, P. E. (2003) · European Surgical Research · doi:10.1159/000073387 · Cited by 139
Sekino, N., Selim, M., & Shehadah, A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02464-4 · Cited by 138
Blecharz-Lang, K. G., Wagner, J., Fries, A., Nieminen-Kelhä, M., Rösner, J., Schneider, U. C., & Vajkoczy, P. (2018) · Translational Stroke Research · doi:10.1007/s12975-018-0614-2 · Cited by 137
Histamine, Neuroinflammation and Neurodevelopment: A Review
Carthy, E. R., & Ellender, T. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.680214 · Cited by 136
Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer’s Disease
Kempuraj, D., Mentor, S., Thangavel, R., Ahmed, M. E., Selvakumar, G. P., Raikwar, S. P., Dubova, I., Zaheer, S., Iyer, S. S., & Zaheer, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00054 · Cited by 136
Evidence questioning cromolyn's effectiveness and selectivity as a ‘mast cell stabilizer' in mice
Oka, T., Kalesnikoff, J., Starkl, P., Tsai, M., & Galli, S. J. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.116 · Cited by 131
Sepsis-Associated Encephalopathy: The Blood–Brain Barrier and the Sphingolipid Rheostat
Kuperberg, S. J., & Wadgaonkar, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00597 · Cited by 125
Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment
Nwafor, D. C., Brichacek, A. L., Mohammad, A. S., Griffith, J., Lucke-Wold, B. P., Benkovic, S. A., Geldenhuys, W. J., Lockman, P. R., & Brown, C. M. (2019) · Journal of Central Nervous System Disease · doi:10.1177/1179573519840652 · Cited by 125
Wang, H., Hong, L.-J., Huang, J.-Y., Jiang, Q., Tao, R.-R., Tan, C., Lu, N.-N., Wang, C.-K., Ahmed, M. M., Lu, Y.-M., et al. (2015) · Cell Research · doi:10.1038/cr.2015.61 · Cited by 123
Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation
Rocha, S. M., Saraiva, T., Cristóvão, A. C., Ferreira, R., Santos, T., Esteves, M., Saraiva, C., Je, G., Cortes, L., Valero, J., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0600-0 · Cited by 117
‘Sealing off the CNS’: cellular and molecular regulation of blood–brain barriergenesis
Siegenthaler, J. A., Sohet, F., & Daneman, R. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.06.006 · Cited by 115
Talreja, J., Kabir, M. H., Filla, M. B., Stechschulte, D. J., & Dileepan, K. N. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01946.x · Cited by 114
Mast Cells in Neurodegenerative Disease
Jones, M. K., Nair, A., & Gupta, M. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00171 · Cited by 108
Sepsis-associated encephalopathy: A review of literature
Fülesdi, B., Molnar, L., Németh, N., & Molnár, C. (2018) · Neurology India · doi:10.4103/0028-3886.227299 · Cited by 100
Brain tight junction protein expression in sepsis in an autopsy series
Erikson, K., Tuominen, H., Vakkala, M., Liisanantti, J. H., Karttunen, T., Syrjälä, H., & Ala-Kokko, T. I. (2020) · Critical Care · doi:10.1186/s13054-020-03101-3 · Cited by 94
Ahıshalı, B., & Kaya, M. (2020) · Methods in molecular biology · doi:10.1007/7651_2020_316 · Cited by 89
Brain Injury–Mediated Neuroinflammatory Response and Alzheimer’s Disease
Kempuraj, D., Ahmed, M. E., Selvakumar, G. P., Thangavel, R., Dhaliwal, A. S., Dubova, I., Mentor, S., Premkumar, K., Saeed, D., Zahoor, H., et al. (2020) · The Neuroscientist · doi:10.1177/1073858419848293 · Cited by 87
Oami, T., Watanabe, E., Hatano, M., Sunahara, S., Fujimura, L., Sakamoto, A., Ito, C., Toshimori, K., & Oda, S. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002016 · Cited by 86
The Role of Mast Cells in Stroke
Parrella, E., Porrini, V., Benarese, M., & Pizzi, M. (2019) · Cells · doi:10.3390/cells8050437 · Cited by 71
Yu, Y., Feng, J., Lian, N., Yang, M., Xie, K., Wang, G., Wang, C., & Yu, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106585 · Cited by 70
Caspase-3 Mediates In Part Hippocampal Apoptosis in Sepsis
Comim, C. M., Barichello, T., Grandgirard, D., Dal‐Pizzol, F., Quevedo, J., & Leib, S. L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8354-x · Cited by 59
Liu, X., Su, P., Meng, S., Aschner, M., Cao, Y., Luo, W., Zheng, G., & Liu, M. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20670 · Cited by 57
Xie, K., Wang, Y., Yin, L., Wang, Y., Chen, H., Mao, X., & Wang, G. (2020) · Shock · doi:10.1097/shk.0000000000001594 · Cited by 53
Fast Estimation of the Blood–Brain Barrier Permeability by Pulling a Ligand through a Lipid Membrane
Thai, N. Q., Theodorakis, P. E., & Li, M. S. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00834 · Cited by 52
Griton, M., Dhaya, I., Nicolas, R., Raffard, G., Periot, O., Hiba, B., & Konsman, J. P. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.10.012 · Cited by 49
Wan, S.-X., Shi, B., Lou, X., Liu, J.-Q., Ma, G., Liang, D., & Ma, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.048 · Cited by 46
Self-citationKempuraj, D., Ahmed, M. E., Selvakumar, G. P., Thangavel, R., Raikwar, S. P., Zaheer, S. A., Iyer, S. S., Govindarajan, R., Nattanmai Chandrasekaran, P., Burton, C., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-020-00288-9 · Cited by 43 · cited 1×
“The activated brain MCs can rapidly release their prestored and newly formed vasoactive mediators and inflammatory cytokines, such as histamine, tryptase, 5-serotonin, TNF-a and a variety of cytokines (8, 11, 12).”
BackgroundWang, Y., Sha, H., Zhou, L., Chen, Y., Zhou, Q., Dong, H., & Qian, Y. (2020) · Mediators of Inflammation · doi:10.1155/2020/8098439 · Cited by 42
The Role Played by Mitochondria in FcεRI-Dependent Mast Cell Activation
Chelombitko, M. A., Chernyak, B. V., Fedorov, A. V., Zinovkin, R. A., Razin, E., & Paruchuru, L. B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584210 · Cited by 40
Valle-Dorado, M. G., Santana‐Gomez, C., Orozco-Suárez, S. A., & Rocha, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.032 · Cited by 36
Raveendran, V. V., Tan, X., Sweeney, M. E., Levant, B., Slusser, J., Stechschulte, D. J., & Dileepan, K. N. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03403.x · Cited by 35
Zong, M.-M., Zhou, Z., Ji, M., Jia, M., Tang, H., & Yang, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00293 · Cited by 34
Xing, W., Huang, P., Lu, Y., Zeng, W., & Zuo, Z. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1631-z · Cited by 31
Kılınç, E., Torun, İ. E., Çetinkaya, A., & Töre, F. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15145 · Cited by 27
Gutiérrez‐Venegas, G., Cruz‐Arrieta, S., Villeda‐Navarro, M., & Méndez‐Mejía, J. A. (2011) · Cell Biology International · doi:10.1042/cbi20100624 · Cited by 17
Lianto, P., Ogutu, F. O., Zhang, Y., He, F., & Che, H. (2018) · Food & Nutrition Research · doi:10.29219/fnr.v62.1084 · Cited by 12
Cited by
Breaking the Barrier: The Role of Proinflammatory Cytokines in BBB Dysfunction
Gryka-Marton, M., Grabowska, A. D., & Szukiewicz, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083532 · Cited by 153
Wang, Y., Tan, Q., Pan, M., Yu, J., Wu, S., Tu, W., Li, M., & Jiang, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112030 · Cited by 71
Yue, J., Mo, L., Zeng, G., Ma, P., Zhang, X., Peng, Y., Zhang, X., Zhou, Y. L., Jiang, Y., Huang, N., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03395-6 · Cited by 64
Self-citationWu, S., Jin, X., Liu, Y., Wang, Z.-Y., Zuo, W., Ma, D., Xiao, Y., Fu, T., Xiao, Y.-L., Chen, L., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03776-7 · Cited by 62
Theoharides, T. C., Twahir, A., & Kempuraj, D. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.10.032 · Cited by 60
Metadata
- Authors
- Yue, J., Tan, Y., Huan, R., Guo, J., Yang, S., Deng, M., Xiong, Y., Han, G., Liu, L., Liu, J., Cheng, Y., Zha, Y., & Zhang, J.
- Affiliations
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Guizhou Provincial People's Hospital (CN)
- Corresponding author
- Cheng, Yuan
- Zha, Yan
- Zhang, Jiqin
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-01
- Volume
- 14
- Pages
- 1090288-1090288
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9929573
- OpenAlex
- W4320076980
- Cited by
- 46
- References
- 51
- Citations by year
- 2026: 20 · 2025: 11 · 2024: 12 · 2023: 3
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81960454, 81960344, 82260533)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Keywords
- mast cell activation, sepsis-associated encephalopathy, blood-brain barrier disruption, cognitive impairment, histamine, histamine H1 receptor, neuroinflammation, disodium cromoglycate, brain microvascular endothelial cells, lipopolysaccharide, tight junction proteins, hippocampus, cecal ligation and puncture
- MeSH terms
- Neuroinflammatory Diseases, Animals, Blood-Brain Barrier, Cromolyn Sodium, Histamine, Lipopolysaccharides, Mast Cells, Sepsis, Endothelial Cells, Mice, Cognitive Dysfunction, Tight Junction Proteins, Sepsis-Associated Encephalopathy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.